In this insightful discussion, Dr. Jo Viney, CEO of Seismic Therapeutic, and Dr. Ryan Peckner, Director of Machine Learning, delve into the exciting intersection of artificial intelligence and immunology. They explore the transformative role AI plays in drug discovery and protein engineering, unveiling its potential to innovate antibody development and enhance therapeutic efficacy. The duo also addresses the challenges in integrating AI into clinical trials and underscores the importance of human expertise alongside AI for reliable scientific advancements.
